280 related articles for article (PubMed ID: 20215547)
41. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
Gründker C; Föst C; Fister S; Nolte N; Günthert AR; Emons G
Breast Cancer Res; 2010; 12(4):R49. PubMed ID: 20630060
[TBL] [Abstract][Full Text] [Related]
42. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
[TBL] [Abstract][Full Text] [Related]
43. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
44. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
45. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
46. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer.
Li Y; Zhao H; Wang Y; Zheng H; Yu W; Chai H; Zhang J; Falck JR; Guo AM; Yue J; Peng R; Yang J
Toxicol Appl Pharmacol; 2013 Oct; 272(1):37-48. PubMed ID: 23747687
[TBL] [Abstract][Full Text] [Related]
47. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
[TBL] [Abstract][Full Text] [Related]
48. Ets-1 controls breast cancer cell balance between invasion and growth.
Furlan A; Vercamer C; Bouali F; Damour I; Chotteau-Lelievre A; Wernert N; Desbiens X; Pourtier A
Int J Cancer; 2014 Nov; 135(10):2317-28. PubMed ID: 24706481
[TBL] [Abstract][Full Text] [Related]
49. Metformin induces unique biological and molecular responses in triple negative breast cancer cells.
Liu B; Fan Z; Edgerton SM; Deng XS; Alimova IN; Lind SE; Thor AD
Cell Cycle; 2009 Jul; 8(13):2031-40. PubMed ID: 19440038
[TBL] [Abstract][Full Text] [Related]
50. The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways.
Guerram M; Jiang ZZ; Yousef BA; Hamdi AM; Hassan HM; Yuan ZQ; Luo HW; Zhu X; Zhang LY
Oncotarget; 2015 Sep; 6(26):21865-77. PubMed ID: 26068969
[TBL] [Abstract][Full Text] [Related]
51. Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway.
Cao J; Tong C; Liu Y; Wang J; Ni X; Xiong MM
Biomed Pharmacother; 2017 Dec; 96():450-458. PubMed ID: 29031204
[TBL] [Abstract][Full Text] [Related]
52. Oral administration of penta-O-galloyl-β-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.
Lee HJ; Seo NJ; Jeong SJ; Park Y; Jung DB; Koh W; Lee HJ; Lee EO; Ahn KS; Ahn KS; Lü J; Kim SH
Carcinogenesis; 2011 Jun; 32(6):804-11. PubMed ID: 21289371
[TBL] [Abstract][Full Text] [Related]
53. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
54. Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
Linher-Melville K; Nashed MG; Ungard RG; Haftchenary S; Rosa DA; Gunning PT; Singh G
PLoS One; 2016; 11(8):e0161202. PubMed ID: 27513743
[TBL] [Abstract][Full Text] [Related]
55. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
Wang-Johanning F; Rycaj K; Plummer JB; Li M; Yin B; Frerich K; Garza JG; Shen J; Lin K; Yan P; Glynn SA; Dorsey TH; Hunt KK; Ambs S; Johanning GL
J Natl Cancer Inst; 2012 Feb; 104(3):189-210. PubMed ID: 22247020
[TBL] [Abstract][Full Text] [Related]
56. A soluble truncated cadherin induces breast cancer cell apoptosis and growth inhibition.
Shi XY; Lu H; Li WL; Tang HL; Xiong JJ; Zhang JQ; Opolon P; Legrand C; Perricaudet M; Li H
J Cancer Res Clin Oncol; 2006 Sep; 132(9):561-71. PubMed ID: 16763806
[TBL] [Abstract][Full Text] [Related]
57. Inhibition on the growth of human MDA-MB-231 breast cancer cells in vitro and tumor growth in a mouse xenograft model by Se-containing polysaccharides from Pyracantha fortuneana.
Yuan C; Wang C; Wang J; Kumar V; Anwar F; Xiao F; Mushtaq G; Liu Y; Kamal MA; Yuan D
Nutr Res; 2016 Nov; 36(11):1243-1254. PubMed ID: 27865619
[TBL] [Abstract][Full Text] [Related]
58. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
[TBL] [Abstract][Full Text] [Related]
59. Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.
Baranwal S; Wang Y; Rathinam R; Lee J; Jin L; McGoey R; Pylayeva Y; Giancotti F; Blobe GC; Alahari SK
J Natl Cancer Inst; 2011 Oct; 103(20):1513-28. PubMed ID: 21917605
[TBL] [Abstract][Full Text] [Related]
60. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.
Wang F; Hansen RK; Radisky D; Yoneda T; Barcellos-Hoff MH; Petersen OW; Turley EA; Bissell MJ
J Natl Cancer Inst; 2002 Oct; 94(19):1494-503. PubMed ID: 12359858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]